Clinical Trials Information

Participants Needed for Critical Limb Ischemia Study

Previous studies have shown that adult CD34+ stem cells could be involved in the creation of new blood vessels, and this therapy is being investigated to see if it can be an effective treatment for Critical Limb Ischemia.

A new study evaluating an investigational treatment using the patient's own CD34+ stem cells collected from peripheral blood is being conducted to determine if this treatment could improve vascular circulation, help heal wounds, and possibly reduce the incidence and/or severity of lower limb amputation.

To qualify for this study, a patient must meet the following criteria:

21-80 years of age
Rutherford Class IV or V Critical Limb Ischemia
Considered an unsuitable candidate for conventional revascularization, or have failed previous attempts.
Be at least one month away from amputation.

Qualified participants will receive study-related laboratory tests, evaluations and study treatment at no cost. Reasonable transportation costs may also be provided.

Click here for more information about the study on the ClinicalTrials.gov Web site.

Links to Other Studies on ClinicalTrials.gov - a Service of the National Institutes of Health

Society for Vascular Surgery - 633 N. St. Clair, 24th Floor; Chicago, IL 60611; Phone: 312-334-2300 or 800-258-7188; Fax: 312-334-2320; Email: vascular@vascularsociety.org
© 2009 VascularWeb. All rights reserved. Use of the VascularWeb site constitutes acceptance of all of the policies, rules and regulations for the site.